healthcare News
Nkarta misses Q4 estimates as cash runway extends to 2029
Biotech posts wider quarterly loss but advances autoimmune trials amid oversold conditions
Corcept surges on FDA approval for ovarian cancer drug
Relacorilant approval for platinum-resistant ovarian cancer comes 3 months ahead of schedule, analysts see 56% upside
Sarepta surges 28% on siRNA trial data for muscular dystrophy
Positive Phase 1/2 results for SRP-1001 and SRP-1003 programs validate pipeline expansion beyond gene therapy
EDAP TMS shares surge on record 2025 HIFU revenue growth
French medical device company posts 36-38% annual revenue increase, guides to 34-45% growth in 2026
KalVista misses earnings but EKTERLY launch gains momentum
Oral HAE treatment captures 20% of US market as company eyes profitability
Kiora Pharmaceuticals FY2025 loss widens to $10.8M, two Phase 2 trials underway
Clinical-stage biotech posts loss after 2024's Théa payment; cash runway extends into late 2027
BioCardia shares plunge as cash runway shrinks to under four months
Clinical-stage biotech reports $2.5M cash position against $7.4M annual burn rate, with no revenue generated in fiscal 2025
Fractyl shares tumble despite strong clinical data in GLP-1 weight maintenance trial
Pivotal REMAIN-1 trial randomization complete with 70% reduction in weight regain, but stock nears 52-week lows as cash burn worries persist